ArticleAnnals of medicine2026
Multi-trajectories of serum uric acid/high density lipoprotein cholesterol ratio and fasting plasma glucose in chronic kidney disease.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the associations of longitudinal trajectories of the serum uric acid to high-density lipoprotein cholesterol ratio (UHR) and fasting plasma glucose (FPG) with chronic kidney disease (CKD) risk.
methodsIn this retrospective cohort study, we included 7,541 adults who underwent at least three annual health examinations. Cox proportional hazards models were used to evaluate associations of UHR and FPG (in quartiles) with incident CKD. Group-based multi-trajectory modeling (GBMTM) was subsequently applied to identify distinct joint trajectories of UHR and FPG.
resultsDuring follow-up, 558 participants developed CKD (incidence 7.40%). In fully adjusted Cox models, higher UHR quartiles remained independently associated with increased CKD risk. The association for FPG was attenuated after full adjustment.GBMTM identified four joint trajectory groups: Group 1(low UHR-low FPG), Group 2(moderate UHR-moderate FPG), Group 3(moderate-high UHR with fluctuating moderate FPG), and Group 4(high UHR with fluctuating moderate FPG). Compared to Group 1, the adjusted hazard ratios (95% CI) for CKD were 1.34 (1.05 ∼ 1.70) for Group 2, 2.31 (1.73 ∼ 3.09) for Group 3, and 4.21 (2.88 ∼ 6.15) for Group 4. Subgroup analyses generally supported these findings.
conclusionsWhile elevated UHR is independently associated with the risk of developing CKD, the association for FPG was attenuated after full adjustment. The joint trajectory analysis highlights that their dynamic co-evolution is significantly associated with CKD risk, identifying a high-risk phenotype that may inform early risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.